Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

Systematic Review: Gene Expression Profiling Assays in Early-Stage Breast Cancer

(2013) Luigi Marchionni et al.   ANNALS OF INTERNAL MEDICINE

Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma

(2012) Fabien Reyal et al.   PLoS One

Is gene array testing to be considered routine now?

(2011) Soonmyung Paik   BREAST

High False-Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study

(2011) David J. Dabbs et al.   JOURNAL OF CLINICAL ONCOLOGY

High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy

(2010) Yasuto Naoi et al.   CANCER

Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis

(2010) Otto Metzger Filho et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories

(2010) Frederick L. Baehner et al.   JOURNAL OF CLINICAL ONCOLOGY

Microarray-Based Determination of Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Status in Breast Cancer

(2009) P. Roepman et al.   CLINICAL CANCER RESEARCH

Genomic Grade Index Is Associated With Response to Chemotherapy in Patients With Breast Cancer

(2009) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of prognostic gene expression signatures for breast cancer

(2008) Benjamin Haibe-Kains et al.   BMC GENOMICS

Problems and Solutions in the Evaluation of Hormone Receptors in Breast Cancer

(2008) D. Craig Allred   JOURNAL OF CLINICAL ONCOLOGY

Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory

(2008) Sunil S. Badve et al.   JOURNAL OF CLINICAL ONCOLOGY

Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer

(2008) J. S. Ross et al.   ONCOLOGIST

Understanding the Molecular Basis of Histologic Grade

(2008) M. Ignatiadis et al.   PATHOBIOLOGY

Gene-expression assays: New tools to individualize treatment of early-stage breast cancer

(2007) E. Dobbe et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY